GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
၂,၈၁၈.၉၀ ₹
arrow_downward
-၀.၇၇%(-၂၂.၀၀) 1D
စက် ၁၁, GMT+၅:၃၀ ၁၅:၃၀:၀၁ · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
၂,၈၄၀.၉၀ ₹
High
၂,၈၆၃.၅၀ ₹
Low
၂,၇၉၃.၉၀ ₹
Mkt. cap
ဋေ ၄.၇၈ သ
Avg. vol.
၀.၀၀
Volume
၃.၈၄ သောင်း
Dividend
၂.၀၂%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၄.၇၁
52-wk high
၃,၁၂၀.၇၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Open
၂,၈၄၀.၉၀ ₹
High
၂,၈၆၃.၅၀ ₹
Low
၂,၇၉၃.၉၀ ₹
Mkt. cap
ဋေ ၄.၇၈ သ
Avg. vol.
၀.၀၀
Volume
၃.၈၄ သောင်း
Dividend
၂.၀၂%
Quarterly dividend
၁၄.၂၅ ₹
Ex-dividend date
၂၀၂၆ မေ ၂၉
P/E ratio
၄၄.၇၁
52-wk high
၃,၁၂၀.၇၀ ₹
52-wk low
၂,၀၈၈.၁၀ ₹
EPS
၆၃.၀၅ ₹
Shares outstanding
၁၆.၉၄ ကုဋေ
No. of employees
၃ ထောင်
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd